About Universitatsklinikum Freiburg - Klinik fur Innere Medizin I
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Universitatsklinikum Freiburg - Klinik fur Innere Medizin I
During the past decade, Universitatsklinikum Freiburg - Klinik fur Innere Medizin I conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 8 clinical trials were completed, i.e. on
average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Universitatsklinikum Freiburg - Klinik fur Innere Medizin I" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Celgene" with 3 trials
sponsored, "Incyte Corporation" with 1 trials sponsored, "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitatsklinikum Freiburg - Klinik fur Innere Medizin I"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Universitatsklinikum Freiburg - Klinik fur Innere Medizin I
According to Clinical.Site data, the most researched conditions in "Universitatsklinikum Freiburg - Klinik fur Innere Medizin I" are
"Ulcerative Colitis" (2 trials), "B-cell Chronic Lymphocytic Leukemia" (1 trials), "Cancer" (1 trials), "Crohn Disease" (1 trials) and "Essential Thrombocythemia (ET)" (1 trials). Many other conditions were trialed in "Universitatsklinikum Freiburg - Klinik fur Innere Medizin I" in a lesser frequency.
Clinical Trials Intervention Types at Universitatsklinikum Freiburg - Klinik fur Innere Medizin I
Most popular intervention types in "Universitatsklinikum Freiburg - Klinik fur Innere Medizin I" are "Drug" (11 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Atezolizumab" (2 trials), "Lenalidomide" (2 trials), "Alectinib" (1 trials) and "BAT" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Universitatsklinikum Freiburg - Klinik fur Innere Medizin I
The vast majority of trials in "Universitatsklinikum Freiburg - Klinik fur Innere Medizin I" are
12 trials for "All" genders.
Clinical Trials Status at Universitatsklinikum Freiburg - Klinik fur Innere Medizin I
Currently, there are NaN active trials in "Universitatsklinikum Freiburg - Klinik fur Innere Medizin I".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Universitatsklinikum Freiburg - Klinik fur Innere Medizin I,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Universitatsklinikum Freiburg - Klinik fur Innere Medizin I, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".